However, they also raise a cautionary note that a better understanding of the role of the IGF-IR in regulating the delicate balance between glioma cell death, dormancy and proliferation will be critical to the optimization of this approach and to effective control of residual disease. This evidence concerns the gene IGF1R and central nervous system cancer.